<mods:mods xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd" version="3.3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mods="http://www.loc.gov/mods/v3"><mods:titleInfo><mods:title>YURAK ISHEMIK KASALLIGI MAVJUD BOʻLGAN BEMORLARDA GIPOLIPIDEMIK TERAPIYANING SAMARADORLIGI</mods:title></mods:titleInfo><mods:name type="personal"><mods:namePart type="given">Doston</mods:namePart><mods:namePart type="family">Qobilov</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:abstract>Ushbu tezisda yurak ishemik kasalligi (YIK) bilan og‘rigan bemorlarda gipolipidemik terapiyaning samaradorligi tahlil qilinadi. YIK va dislipidemiya o‘rtasidagi bog‘liqlik, gipolipidemik dori vositalarining ta’siri va bemorlardagi klinik ko‘rsatkichlar o‘rganiladi. Tadqiqotda statinlar va boshqa gipolipidemik preparatlar bilan davolashning kardiovaskulyar natijalarga ta’siri tahlil etiladi. Maqsad — gipolipidemik terapiyaning samaradorligini baholash va klinikada qo‘llash bo‘yicha tavsiyalar ishlab chiqish.</mods:abstract><mods:originInfo><mods:dateIssued encoding="iso8601">2025-05-24</mods:dateIssued></mods:originInfo><mods:originInfo><mods:publisher>Research Science and Innovation House</mods:publisher></mods:originInfo><mods:genre>Maqola</mods:genre></mods:mods>